Bicycle Therapeutics (BCYC) Earnings Date & Reports

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BCYC is expected to report earnings to rise 5.77% to -93 cents per share on July 31

Bicycle Therapeutics BCYC Stock Earnings Reports

Q2'25

Est.

$-0.93

Q1'25

Missed

by $0.03

Q4'24

Beat

by $0.11

Q3'24

Beat

by $0.06

Q2'24

Beat

by $0.36

The last earnings report on May 01 showed earnings per share of -87 cents, missing the estimate of -85 cents. With 497.93K shares outstanding, the current market capitalization sits at 577.58M.

View a ticker or compare two or three

Compare

BCYC